More on ANIP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $72.28 |
|
|||
| Open | $72.65 | ||||
| 52 Wk High | $70.92 | ||||
| 52 Wk Low | $26.80 | ||||
| Day High | $73.08 | ||||
| Day Low | $71.50 | ||||
| P/E | N/A | ||||
| EPS | $-0.96 | ||||
| Volume | 333,933 | ||||
- Form 4 ANI PHARMACEUTICALS INC For: Oct 15 Filed by: Lalwani Nikhil
- Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil
- Form 4 ANI PHARMACEUTICALS INC For: Oct 13 Filed by: Cook Meredith
- ANI Pharmaceuticals reports positive phase 4 uveitis trial data
- ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 An
- Form 4 ANI PHARMACEUTICALS INC For: Sep 29 Filed by: CAREY STEPHEN P.
- ANI Pharmaceuticals to present eye implant data at AAO 2026 meeting
- ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
- ANI Pharmaceuticals gets FDA approval for generic everolimus suspension
- ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
Entities mentioned with ANIP
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Raising Prices | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Guggenheim | View Related Stories »
- Show More...
